New mini lung machine tested on smallest patients
NCT ID NCT06750536
First seen Jan 09, 2026 · Last updated May 22, 2026 · Updated 21 times
Summary
This study is testing a new device called the MiniLung petite kit in 20 newborns and children weighing 2 to 8 kilograms who have severe breathing or heart failure. The device is used with a machine that takes over the work of the lungs and heart (ECMO). Researchers want to see if it is safe and if it improves oxygen levels and blood flow within the first day of use. This is an observational study, meaning no new treatments are given—just careful monitoring of the device's performance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Universitätsklinikum Mannheim
RECRUITINGMannheim, 68167, Germany
Contact Email: •••••@•••••
-
Universitätsklinkum Bonn
RECRUITINGBonn, North Rhine-Westphalia, 53127, Germany
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.